Ikarian Capital, LLC 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:32 pm Sale | 2021-12-31 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Ikarian Capital, LLC | 36,576 0.200% | -1,027,385 (-96.56%) | Filing |